Cancer-related arterial thromboembolic events

Cancer is associated with a hypercoagulable state and is a well-known independent risk factor for venous thromboembolism, whereas the association between cancer and arterial thromboembolism is less well established. Arterial thromboembolism, primarily defined as myocardial infarction or stroke is si...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Archives of cardiovascular diseases 2024-01, Vol.117 (1), p.101-113
Hauptverfasser: Pernod, Gilles, Cohen, Ariel, Mismetti, Patrick, Sanchez, Olivier, Mahé, Isabelle
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 113
container_issue 1
container_start_page 101
container_title Archives of cardiovascular diseases
container_volume 117
creator Pernod, Gilles
Cohen, Ariel
Mismetti, Patrick
Sanchez, Olivier
Mahé, Isabelle
description Cancer is associated with a hypercoagulable state and is a well-known independent risk factor for venous thromboembolism, whereas the association between cancer and arterial thromboembolism is less well established. Arterial thromboembolism, primarily defined as myocardial infarction or stroke is significantly more frequent in patients with cancer, independently of vascular risk factors and associated with a three-fold increase in the risk of mortality. Patients with brain cancer, lung cancer, colorectal cancer and pancreatic cancer have the highest relative risk of developing arterial thromboembolism. Antithrombotic treatments should be used with caution due to the increased risk of haemorrhage, as specified in current practice guidelines.
doi_str_mv 10.1016/j.acvd.2023.11.007
format Article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_04669736v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2899374454</sourcerecordid><originalsourceid>FETCH-LOGICAL-c288t-d74e2c360830bdbc609ac99982cbb6d22621ff396058955d9b8b2e9f892344363</originalsourceid><addsrcrecordid>eNo9kD1PwzAQhi0EolD4AwyoIwwJ9jn-GqsKKFIlFpgt27moqZKm2Gkl_j2JWjqc7nR63nd4CHlgNGeUyZdN7sKhzIECzxnLKVUX5IZpJTJgoC_PN5cTcpvShlIJSslrMuGaCgVC3ZBs4bYBYxaxcT2WMxd7jLVrZv06dq3vcJimDjM84LZPd-Sqck3C-9Oeku-316_FMlt9vn8s5qssgNZ9VqoCIXBJNae-9EFS44IxRkPwXpYAElhVcSOp0EaI0njtAU2lDfCi4JJPyfOxd-0au4t16-Kv7Vxtl_OVHX-0kNIoLg9sYJ-O7C52P3tMvW3rFLBp3Ba7fbKgjeGqKEQxoHBEQ-xSiliduxm1o1K7saNSOyq1jNlB6RB6PPXvfYvlOfLvkP8BblRwug</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2899374454</pqid></control><display><type>article</type><title>Cancer-related arterial thromboembolic events</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Pernod, Gilles ; Cohen, Ariel ; Mismetti, Patrick ; Sanchez, Olivier ; Mahé, Isabelle</creator><creatorcontrib>Pernod, Gilles ; Cohen, Ariel ; Mismetti, Patrick ; Sanchez, Olivier ; Mahé, Isabelle ; INNOVTE CAT Working Group</creatorcontrib><description>Cancer is associated with a hypercoagulable state and is a well-known independent risk factor for venous thromboembolism, whereas the association between cancer and arterial thromboembolism is less well established. Arterial thromboembolism, primarily defined as myocardial infarction or stroke is significantly more frequent in patients with cancer, independently of vascular risk factors and associated with a three-fold increase in the risk of mortality. Patients with brain cancer, lung cancer, colorectal cancer and pancreatic cancer have the highest relative risk of developing arterial thromboembolism. Antithrombotic treatments should be used with caution due to the increased risk of haemorrhage, as specified in current practice guidelines.</description><identifier>ISSN: 1875-2136</identifier><identifier>EISSN: 1875-2128</identifier><identifier>DOI: 10.1016/j.acvd.2023.11.007</identifier><identifier>PMID: 38057257</identifier><language>eng</language><publisher>Netherlands: Elsevier ; Société française de cardiologie [2008-....]</publisher><subject>Atrial Fibrillation - complications ; Cancer ; Cardiology and cardiovascular system ; Hemorrhage - chemically induced ; Human health and pathology ; Humans ; Life Sciences ; Myocardial Infarction - complications ; Neoplasms - complications ; Neoplasms - diagnosis ; Neoplasms - epidemiology ; Risk Factors ; Stroke - etiology ; Venous Thromboembolism - diagnosis ; Venous Thromboembolism - epidemiology ; Venous Thromboembolism - etiology</subject><ispartof>Archives of cardiovascular diseases, 2024-01, Vol.117 (1), p.101-113</ispartof><rights>Copyright © 2023 Elsevier Masson SAS. All rights reserved.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c288t-d74e2c360830bdbc609ac99982cbb6d22621ff396058955d9b8b2e9f892344363</cites><orcidid>0000-0002-1779-6936</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38057257$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://u-picardie.hal.science/hal-04669736$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Pernod, Gilles</creatorcontrib><creatorcontrib>Cohen, Ariel</creatorcontrib><creatorcontrib>Mismetti, Patrick</creatorcontrib><creatorcontrib>Sanchez, Olivier</creatorcontrib><creatorcontrib>Mahé, Isabelle</creatorcontrib><creatorcontrib>INNOVTE CAT Working Group</creatorcontrib><title>Cancer-related arterial thromboembolic events</title><title>Archives of cardiovascular diseases</title><addtitle>Arch Cardiovasc Dis</addtitle><description>Cancer is associated with a hypercoagulable state and is a well-known independent risk factor for venous thromboembolism, whereas the association between cancer and arterial thromboembolism is less well established. Arterial thromboembolism, primarily defined as myocardial infarction or stroke is significantly more frequent in patients with cancer, independently of vascular risk factors and associated with a three-fold increase in the risk of mortality. Patients with brain cancer, lung cancer, colorectal cancer and pancreatic cancer have the highest relative risk of developing arterial thromboembolism. Antithrombotic treatments should be used with caution due to the increased risk of haemorrhage, as specified in current practice guidelines.</description><subject>Atrial Fibrillation - complications</subject><subject>Cancer</subject><subject>Cardiology and cardiovascular system</subject><subject>Hemorrhage - chemically induced</subject><subject>Human health and pathology</subject><subject>Humans</subject><subject>Life Sciences</subject><subject>Myocardial Infarction - complications</subject><subject>Neoplasms - complications</subject><subject>Neoplasms - diagnosis</subject><subject>Neoplasms - epidemiology</subject><subject>Risk Factors</subject><subject>Stroke - etiology</subject><subject>Venous Thromboembolism - diagnosis</subject><subject>Venous Thromboembolism - epidemiology</subject><subject>Venous Thromboembolism - etiology</subject><issn>1875-2136</issn><issn>1875-2128</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kD1PwzAQhi0EolD4AwyoIwwJ9jn-GqsKKFIlFpgt27moqZKm2Gkl_j2JWjqc7nR63nd4CHlgNGeUyZdN7sKhzIECzxnLKVUX5IZpJTJgoC_PN5cTcpvShlIJSslrMuGaCgVC3ZBs4bYBYxaxcT2WMxd7jLVrZv06dq3vcJimDjM84LZPd-Sqck3C-9Oeku-316_FMlt9vn8s5qssgNZ9VqoCIXBJNae-9EFS44IxRkPwXpYAElhVcSOp0EaI0njtAU2lDfCi4JJPyfOxd-0au4t16-Kv7Vxtl_OVHX-0kNIoLg9sYJ-O7C52P3tMvW3rFLBp3Ba7fbKgjeGqKEQxoHBEQ-xSiliduxm1o1K7saNSOyq1jNlB6RB6PPXvfYvlOfLvkP8BblRwug</recordid><startdate>202401</startdate><enddate>202401</enddate><creator>Pernod, Gilles</creator><creator>Cohen, Ariel</creator><creator>Mismetti, Patrick</creator><creator>Sanchez, Olivier</creator><creator>Mahé, Isabelle</creator><general>Elsevier ; Société française de cardiologie [2008-....]</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0002-1779-6936</orcidid></search><sort><creationdate>202401</creationdate><title>Cancer-related arterial thromboembolic events</title><author>Pernod, Gilles ; Cohen, Ariel ; Mismetti, Patrick ; Sanchez, Olivier ; Mahé, Isabelle</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c288t-d74e2c360830bdbc609ac99982cbb6d22621ff396058955d9b8b2e9f892344363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Atrial Fibrillation - complications</topic><topic>Cancer</topic><topic>Cardiology and cardiovascular system</topic><topic>Hemorrhage - chemically induced</topic><topic>Human health and pathology</topic><topic>Humans</topic><topic>Life Sciences</topic><topic>Myocardial Infarction - complications</topic><topic>Neoplasms - complications</topic><topic>Neoplasms - diagnosis</topic><topic>Neoplasms - epidemiology</topic><topic>Risk Factors</topic><topic>Stroke - etiology</topic><topic>Venous Thromboembolism - diagnosis</topic><topic>Venous Thromboembolism - epidemiology</topic><topic>Venous Thromboembolism - etiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pernod, Gilles</creatorcontrib><creatorcontrib>Cohen, Ariel</creatorcontrib><creatorcontrib>Mismetti, Patrick</creatorcontrib><creatorcontrib>Sanchez, Olivier</creatorcontrib><creatorcontrib>Mahé, Isabelle</creatorcontrib><creatorcontrib>INNOVTE CAT Working Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Archives of cardiovascular diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pernod, Gilles</au><au>Cohen, Ariel</au><au>Mismetti, Patrick</au><au>Sanchez, Olivier</au><au>Mahé, Isabelle</au><aucorp>INNOVTE CAT Working Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cancer-related arterial thromboembolic events</atitle><jtitle>Archives of cardiovascular diseases</jtitle><addtitle>Arch Cardiovasc Dis</addtitle><date>2024-01</date><risdate>2024</risdate><volume>117</volume><issue>1</issue><spage>101</spage><epage>113</epage><pages>101-113</pages><issn>1875-2136</issn><eissn>1875-2128</eissn><abstract>Cancer is associated with a hypercoagulable state and is a well-known independent risk factor for venous thromboembolism, whereas the association between cancer and arterial thromboembolism is less well established. Arterial thromboembolism, primarily defined as myocardial infarction or stroke is significantly more frequent in patients with cancer, independently of vascular risk factors and associated with a three-fold increase in the risk of mortality. Patients with brain cancer, lung cancer, colorectal cancer and pancreatic cancer have the highest relative risk of developing arterial thromboembolism. Antithrombotic treatments should be used with caution due to the increased risk of haemorrhage, as specified in current practice guidelines.</abstract><cop>Netherlands</cop><pub>Elsevier ; Société française de cardiologie [2008-....]</pub><pmid>38057257</pmid><doi>10.1016/j.acvd.2023.11.007</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0002-1779-6936</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1875-2136
ispartof Archives of cardiovascular diseases, 2024-01, Vol.117 (1), p.101-113
issn 1875-2136
1875-2128
language eng
recordid cdi_hal_primary_oai_HAL_hal_04669736v1
source MEDLINE; Elsevier ScienceDirect Journals; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Atrial Fibrillation - complications
Cancer
Cardiology and cardiovascular system
Hemorrhage - chemically induced
Human health and pathology
Humans
Life Sciences
Myocardial Infarction - complications
Neoplasms - complications
Neoplasms - diagnosis
Neoplasms - epidemiology
Risk Factors
Stroke - etiology
Venous Thromboembolism - diagnosis
Venous Thromboembolism - epidemiology
Venous Thromboembolism - etiology
title Cancer-related arterial thromboembolic events
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T22%3A43%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cancer-related%20arterial%20thromboembolic%20events&rft.jtitle=Archives%20of%20cardiovascular%20diseases&rft.au=Pernod,%20Gilles&rft.aucorp=INNOVTE%20CAT%20Working%20Group&rft.date=2024-01&rft.volume=117&rft.issue=1&rft.spage=101&rft.epage=113&rft.pages=101-113&rft.issn=1875-2136&rft.eissn=1875-2128&rft_id=info:doi/10.1016/j.acvd.2023.11.007&rft_dat=%3Cproquest_hal_p%3E2899374454%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2899374454&rft_id=info:pmid/38057257&rfr_iscdi=true